| NCT Number | NCT07756801 |
| Lead Sponsor | Ottawa Heart Institute Research Corporation |
| Conditions | Hypervolemia, Cardiogenic Shock, Renal Replacement Therapy |
| Enrollment | 456 participants |
| Start Date | 2026-09-01 |
| Primary Completion | 2027-09 (estimated) |
| Study Completion | 2031-09 (estimated) |
| Updated on ClinicalTrials.gov | 2026-08-11 |